Literature DB >> 35788561

The fibrogenic niche in kidney fibrosis: components and mechanisms.

Li Li1, Haiyan Fu1, Youhua Liu2,3.   

Abstract

Kidney fibrosis, characterized by excessive deposition of extracellular matrix (ECM) that leads to tissue scarring, is the final common outcome of a wide variety of chronic kidney diseases. Rather than being distributed uniformly across the kidney parenchyma, renal fibrotic lesions initiate at certain focal sites in which the fibrogenic niche is formed in a spatially confined fashion. This niche provides a unique tissue microenvironment that is orchestrated by a specialized ECM network consisting of de novo-induced matricellular proteins. Other structural elements of the fibrogenic niche include kidney resident and infiltrated inflammatory cells, extracellular vesicles, soluble factors and metabolites. ECM proteins in the fibrogenic niche recruit soluble factors including WNTs and transforming growth factor-β from the extracellular milieu, creating a distinctive profibrotic microenvironment. Studies using decellularized ECM scaffolds from fibrotic kidneys show that the fibrogenic niche autonomously promotes fibroblast proliferation, tubular injury, macrophage activation and endothelial cell depletion, pathological features that recapitulate key events in the pathogenesis of chronic kidney disease. The concept of the fibrogenic niche represents a paradigm shift in understanding of the mechanism of kidney fibrosis that could lead to the development of non-invasive biomarkers and novel therapies not only for chronic kidney disease, but also for fibrotic diseases of other organs.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35788561     DOI: 10.1038/s41581-022-00590-z

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   42.439


  164 in total

Review 1.  Extracellular matrix as a driver of progressive fibrosis.

Authors:  Jeremy Herrera; Craig A Henke; Peter B Bitterman
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 2.  Chronic Kidney Disease Diagnosis and Management: A Review.

Authors:  Teresa K Chen; Daphne H Knicely; Morgan E Grams
Journal:  JAMA       Date:  2019-10-01       Impact factor: 56.272

Review 3.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

4.  Renal fibrosis in 2015: Understanding the mechanisms of kidney fibrosis.

Authors:  Dong Zhou; Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2015-12-30       Impact factor: 28.314

Review 5.  The next generation of therapeutics for chronic kidney disease.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Nat Rev Drug Discov       Date:  2016-05-27       Impact factor: 84.694

6.  Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.

Authors:  Vikas Gupta; Ishaan Gupta; Jiwoon Park; Yaron Bram; Robert E Schwartz
Journal:  Gastroenterology       Date:  2020-04-11       Impact factor: 22.682

Review 7.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

8.  Tenascin-C Is a Major Component of the Fibrogenic Niche in Kidney Fibrosis.

Authors:  Haiyan Fu; Yuan Tian; Lili Zhou; Dong Zhou; Roderick J Tan; Donna B Stolz; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

Review 9.  Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis.

Authors:  Sara Lovisa; Michael Zeisberg; Raghu Kalluri
Journal:  Trends Endocrinol Metab       Date:  2016-06-29       Impact factor: 12.015

10.  Resolving the fibrotic niche of human liver cirrhosis at single-cell level.

Authors:  P Ramachandran; R Dobie; J R Wilson-Kanamori; E F Dora; B E P Henderson; N T Luu; J R Portman; K P Matchett; M Brice; J A Marwick; R S Taylor; M Efremova; R Vento-Tormo; N O Carragher; T J Kendall; J A Fallowfield; E M Harrison; D J Mole; S J Wigmore; P N Newsome; C J Weston; J P Iredale; F Tacke; J W Pollard; C P Ponting; J C Marioni; S A Teichmann; N C Henderson
Journal:  Nature       Date:  2019-10-09       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.